Charles K. Brown - Concepedia

Author

Charles K. Brown

Also Known As

C K Brown, C Komen Brown, C. K. Brown, C. Komen Brown, C.K. Brown, CHARLES BROWN, CHARLES K. BROWN, Charles Brown, Charles K Brown, Charles K. Brown

Publications

2.8K

Citations

H-Index

103

Concepts

All Affiliations

University of Chicago National Institutes of Health National Cancer Institute University of Pittsburgh East Carolina University

About

Charles K. Brown is an author at University of Chicago specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	21	1.2K
2	Health Sciences	4	4	138
3	Engineering	2	2	49
4	Natural Sciences	2	2	69
5	Education	1	1	29

Charles K. Brown

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Induction of CD8<sup>+</sup>T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma Hideho Okada, Paweł Kaliński, Ryo Ueda, Journal of Clinical Oncology	2010	557
Tumour-endothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cells Nikolai N. Khodarev, Jianqing Yu, Edwardine Labay, Journal of Cell Science	2003	183
Vaccinia as a vector for tumor-directed gene therapy: Biodistribution of a thymidine kinase-deleted mutant Markus Puhlmann, Charles K. Brown, Michael Gnant, Cancer Gene Therapy VaccinationTumor-directed Gene TherapyMedicineImmunologyTherapeutic Vaccine	2000	175
Aggressive Surgical Management of Peritoneal Carcinomatosis With Low Mortality in a High-Volume Tertiary Cancer Center Niraj J. Gusani, Sung W. Cho, Christos Colovos, Annals of Surgical Oncology Surgical OncologyGastrointestinal OncologyPeritoneal CarcinomatosisLow MortalityMedicine	2007	169
High Mobility Group Box I (HMGB1) Release From Tumor Cells After Treatment: Implications for Development of Targeted Chemoimmunotherapy Xiang Da Dong, Norimasa Ito, Michael T. Lotze, Journal of Immunotherapy Tumor BiologyCell TherapyCancer ImmunosurveillanceMedicineImmune Effectors	2007	125
Intraarterial calcium stimulation and intraoperative ultrasonography in the localization and resection of insulinomas Charles K. Brown, David L. Bartlett, John L. Doppman, Surgery Minimally Invasive ProcedureSurgical PathologyInterventional RadiologyEndocrine SurgerySurgery	1997	109
Multicenter, Phase II Study of Axitinib, a Selective Second-Generation Inhibitor of Vascular Endothelial Growth Factor Receptors 1, 2, and 3, in Patients with Metastatic Melanoma John P. Fruehauf, Jose Lutzky, David H. McDermott, Clinical Cancer Research	2011	106
Thymidine Kinase-Deleted Vaccinia Virus Expressing Purine Nucleoside Phosphorylase as a Vector for Tumor-Directed Gene Therapy Markus Puhlmann, Michael Gnant, Charles K. Brown, Human Gene Therapy	1999	93
High Mobility Group B1 Protein Suppresses the Human Plasmacytoid Dendritic Cell Response to TLR9 Agonists P. Popovič, Richard DeMarco, Michael T. Lotze, The Journal of Immunology Adaptive Immune SystemInnate Immune SystemImmunologyImmunologic MechanismInnate Immunity	2006	66
Encouraging early defibrillation: The American Heart Association and automated external defibrillators Richard O. Cummins, William Thies, John A Paraskos, Annals of Emergency Medicine External DefibrillatorsDevice TherapyCardiovascular DiseaseDigital HealthPatient Safety	1990	62

Page 1